Didsbury J R, Uhing R J, Tomhave E, Gerard C, Gerard N, Snyderman R
Department of Medicine, Duke University Medical Center, Durham, NC 27710.
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11564-8. doi: 10.1073/pnas.88.24.11564.
To better define their regulation, formylpeptide and C5a chemoattractant receptor cDNAs were transiently expressed with high efficiency (approximately 35-54%) in human kidney cells. As in neutrophils, both receptors were active in elevating intracellular calcium (ED50 approximately 0.5-1 nM). Agonist-specific desensitization for calcium elevation was observed for both chemoattractant receptors at doses of approximately 1 nM. Heterologous desensitization of formylpeptide, C5a, and alpha 1-adrenergic receptors required high doses of phorbol ester (100 nM phorbol 12-myristate 13-acetate). To further study the phenomenon of desensitization, formylpeptide and C5a receptor cDNAs were cotransfected resulting in approximately 80% of receptor-positive cells expressing both receptors. These cells also possessed endogenous alpha 1-adrenergic receptors. Interestingly, chemoattractant receptors were cross-desensitized by pretreatment with low doses of either C5a or formylmethionylleucylphenylalanine (10 nM) but not by the alpha 1-adrenergic agonist norepinephrine (up to 10 microM). Neither chemoattractant desensitized alpha 1-adrenergic receptors. This phenomenon was reproduced in human neutrophils. These data suggest a previously uncharacterized mechanism of receptor regulation, which is intermediate between homologous and heterologous desensitization. Class desensitization of chemoattractant receptors is less selective than homologous desensitization but is far more efficient and specific than heterologous desensitization. Receptor class desensitization may affect functional classes of receptors via modification of either the receptor or the shared guanine nucleotide-binding regulatory protein.
为了更好地确定它们的调节机制,甲酰肽和C5a趋化因子受体cDNA在人肾细胞中高效瞬时表达(约35 - 54%)。与中性粒细胞一样,两种受体在升高细胞内钙方面均有活性(半数有效浓度约为0.5 - 1 nM)。在约1 nM剂量下,两种趋化因子受体均观察到钙升高的激动剂特异性脱敏现象。甲酰肽、C5a和α1 - 肾上腺素能受体的异源脱敏需要高剂量的佛波酯(100 nM佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯)。为了进一步研究脱敏现象,甲酰肽和C5a受体cDNA共转染,结果约80%的受体阳性细胞同时表达两种受体。这些细胞还具有内源性α1 - 肾上腺素能受体。有趣的是,低剂量的C5a或甲酰甲硫氨酰亮氨酰苯丙氨酸(10 nM)预处理可使趋化因子受体交叉脱敏,但α1 - 肾上腺素能激动剂去甲肾上腺素(高达10 μM)则不能。两种趋化因子均未使α1 - 肾上腺素能受体脱敏。这种现象在人中性粒细胞中也得到了重现。这些数据提示了一种以前未被描述的受体调节机制,它介于同源脱敏和异源脱敏之间。趋化因子受体的类脱敏比同源脱敏选择性低,但比异源脱敏效率高且特异性强得多。受体类脱敏可能通过修饰受体或共享的鸟嘌呤核苷酸结合调节蛋白来影响受体的功能类别。